Thoratec Corporation : The bullish trend is not over
January 02, 2013 at 09:42 am EST
By
Entry price | Target | Stop-loss | Potential |
---|
$37.52 |
$0 |
$36.3 |
-100% |
---|
Thoratec Corporation has still an uptrend and is going toward its highest level.
From a fundamental viewpoint, the company is strong. The Thomson Reuters consensus revised regularly upward EPS estimates of the company for the current year.
Technical patterns are in the green: prices are up for several months. The reversal should continue in the coming trading sessions. The 50-day moving average should help to reach the USD 39.3 mid-term resistance.
Thanks to these good indicators, it seems relevant to take a long position in Thoratec Corporation at the current price. The target price is the USD 39.3 resistance. A stop loss will be fixed under the USD 37 short term because a breakdown of this level would damage technical pattern.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.